Improvement Leadership Academy
The Spring 2024 application cycle will open in December!
This course is designed to guide you through an improvement project you originate and provide you with the skills, tools and agency to become an improvement champion in your local work area. The course will blend instruction on improvement techniques with interactive working sessions in which you can apply what you learn and get feedback from experienced improvement leaders and colleagues to drive your improvement project forward.
Non-clinical and clinical mid-level managers and nurse and physician leaders at Boston Medical Center and Boston Healthnet CHCs.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 18 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Contact Hours: 18 of which 0 are eligible for pharmacology credit
- CME Course Director: David Yuh, MD
- CNE Course Advisor: Deborah Whalen, MSN, MBA, ANP
No planning committee member has any relevant financial relationships to disclose. Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.